MICHELE CARBONELL-SMITH: Open Payments
NPI 1447557160 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,946 in 141 payments from 21 companies in 2025. Trend: 2023 $2,926 · 2024 $2,879 · 2025 $2,946
Food & beverage: $2,928Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $523 |
| GlaxoSmithKline, LLC. | 29 | $500 |
| Insmed, Inc. | 13 | $317 |
| Verona Pharma, Inc. | 16 | $246 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $229 |
| Viatris Specialty LLC | 12 | $204 |
| GENZYME CORPORATION | 7 | $139 |
| United Therapeutics Corporation | 6 | $130 |
| Grifols USA, LLC | 5 | $103 |
| Regeneron Healthcare Solutions, Inc. | 5 | $103 |
Products named: Arikayce, AIRSUPRA, TRELEGY ELLIPTA, Ohtuvayre, DUPIXENT, YUPELRI, NUCALA, Tyvaso.
Industry payments across KY — which companies pay providers there.
